1[12]Bharucha AE, Camilleri M, Haydock S, et al. Effect of serotonin5-HT4 receptor antagonist SB-207266 on gastrointestinal motorand sensory function in human [J]. Gut, 2000, 47 (3): 667674.
2[13]Chiba T, Tbomforde GM, Kost LJ, et al. Motilide accelerated regional gastrointestinal transit in dog [J]. Aliment PharmacolTher ,2000,14(7):955-960.
3[14]Itoh Z. Motilin and cilinical application[J]. Peptide ,1997,18(4):593-608.
4[15]Jailwala J, Imperiale TF,Kroenke K. Pharmacologic treatment ofthe irritable bowel syndrome: a systematic review of randomized,controlled trials[J]. Ann Intern Med ,2000,133(2): 136 - 147.
5[16]Fioramonti J, Christen MO, Dupre I, et al. Effect of a selectivecalcium antagonist, pinaverium bromide, on sensitivity to rectaldistention in experimental inflammation in rats [J]. Gastroenterol, 1997, 112 (Suppl): A731.
7[18]Orihata M, Sarna SK. Inhibition of nitric oxide synthase delaysgastric emptying of solid meals [J]. J Pharmacol Exp Ther,1994,271(2): 660-670.
8[19]Scarpignato C, Pelosini I. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility[J]. Can J Gastroenterol, 1999,13 (Suppl A):50A- 65A.
9[20]Lidums I, Lehmarn A, Cheeklin H, et al. Control of transientlower esophageal sphincter relaxations and reflus by the GABABagonist baclofen in normal subjects[J]. Gastroenterol, 2000,118(1):7-13.
10[21]Delvaux M. Pharmacology and clinical experience with fedotozine[J]. Expert Opin Investig Drugs .2001,10(1) :97-110.
